In 1958 when Miles “Lowell” Edwards teamed up with Dr. Albert Starr to create an artificial heart valve. This invention took just two years and was the first step for the Edwards-Starr team towards their goal of building the first artificial heart.
Edwards Laboratories was created to produce and design this heart valve.
In 1966 the company was acquired by American Hospital Supply Corporation, which was then acquired by Baxter International, who spun-off the company into a publicly traded company.
Today Edwards Lifesciences’s main products are still heart valve devices, including annuloplasty rings, animal tissue valves, and transcatheter heart valves. The company also produces systems that monitor heart function during surgery and surgical supplies.
Edwards Lifesciences trades publicly on the New York Stock Exchange under the ticker symbol EW, is #959 in the Fortune 1000, has 9,100 employees, and had $2.39 billion in revenue in 2014.
Edwards LifesciencesIn 1958 when Miles “Lowell” Edwards teamed up with Dr. Albert Starr to create an artificial heart valve. This invention took just two years and was the first step for the Edwards-Starr team towards their goal of building the first artificial heart.
Edwards Laboratories was created to produce and design this heart valve.
In 1966 the company was acquired by American Hospital Supply Corporation, which was then acquired by Baxter International, who spun-off the company into a publicly traded company.
History
Today Edwards Lifesciences’s main products are still heart valve devices, including annuloplasty rings, animal tissue valves, and transcatheter heart valves. The company also produces systems that monitor heart function during surgery and surgical supplies.
Edwards Lifesciences trades publicly on the New York Stock Exchange under the ticker symbol EW, is #959 in the Fortune 1000, has 9,100 employees, and had $2.39 billion in revenue in 2014.